FDA Adverse Event Injury Summary report: N

PENTAX

MDR report key: 1040334 · Received May 8, 2008

Report

Report Number
MW5006784
Event Type
Injury
Date Received
May 8, 2008
Date of Event
May 8, 2008
Report Date
May 8, 2008
Product Code
FDS
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

THE PENTAX GASTROSCOPE MODEL EG-29901 IS FITTED WITH BUTTONS TO CONTROL SUCTION AND AIR DELIVERY THROUGH THE SCOPE. THE SUCTION BUTTON IS MARKED WITH A RED DOT ON THE CENTER OF THE OUTER SURFACE TO INDICATE IT IS THE SUCTION BUTTON. THE PENTAX BRONCHOSCOPES ALSO HAVE A SUCTION BUTTON THAT IS IDENTICAL IN EXTERNAL APPEARANCE TO THE GASTROSCOPE SUCTION BUTTON AND WHICH CAN BE PLACED INTO A GASTROSCOPE MODEL EG-29901. WHEN A BRONCHOSCOPE BUTTON IS PLACED IN A GASTROSCOPE, IT APPEARS TO WORK CORRECTLY, HOWEVER, THE SUCTION CHANNEL IS ALWAYS ON, SUCTIONING GAS FROM THE STOMACH, AND PREVENTING INFLATION OF THE STOMACH. WITH A COLLAPSED STOMACH, IT IS NOT POSSIBLE TO PERFORM AN ADEQUATE DIAGNOSTIC EXAMINATION. IN THIS CASE, THE BRONCHOSCOPE BUTTON WAS PLACED IN THE GASTROSCOPE. THE ERROR WAS NOT APPARENT UNTIL AFTER THE SCOPE WAS FOUND NOT TO BE ABLE TO INSUFFLATE THE STOMACH. THE ENDOSCOPY WAS STOPPED AND HAD TO BE REPEATED DUE TO THE ERROR. TWO MONTHS AGO, IN THE SAME FACILITY, AN IDENTICAL ERROR OCCURRED. IN THAT CASE THE ENDOSCOPY WAS REPEATED TWICE BEFORE THE ERROR WAS DISCOVERED BEFORE THE THIRD INSERTION OF THE ENDOSCOPE. AT THAT TIME THE STAFF WAS NOTIFIED OF THE DEFECTIVE DESIGN OF THE SCOPE, AND PLANS WERE MADE TO KEEP BRONCHOSCOPE AND GASTROSCOPE PARTS SEPARATE. THIS SAFETY PLAN HAS NOW BEEN SHOWN TO BE INEFFECTIVE. THE PENTAX DEVICE IS OF DEFECTIVE DESIGN DUE TO PARTS WITH DIFFERENT FUNCTION BEING ABLE TO FIT A DEVICE, THEY ARE NOT INTENDED FOR AND CAUSING AN ENDOSCOPIC PROCEDURE TO BE REPEATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PENTAX GASTROSCOPE FDS EG-29901

Patients

Seq Age Sex Outcome Treatment
1 79 YR Other